Navigation Links
Datascope Adjourns Annual Meeting of Shareholders to January 3, 2008

MONTVALE, N.J., Dec. 20 /PRNewswire-FirstCall/ -- Datascope Corp. (Nasdaq: DSCP) today announced that it has adjourned its Annual Meeting of Shareholders. The Annual Meeting will reconvene on Thursday, January 3, 2008, at 9:00 a.m. Eastern Time at the offices of Dechert LLP, 30 Rockefeller Plaza in New York.

Prior to the closing of the polls at the Annual Meeting, all proxy cards received by Datascope and Ramius Capital were turned over to the independent inspectors of elections, IVS Associates, Inc., for final tabulation and certification. In addition, the results are subject to the customary review and challenge period. Final results will be released after the votes have been tabulated and certified.

The Company noted that while the results of the election of directors are not official at this time, based on a preliminary review of the proxies submitted, it appears that one of Datascope's directors has been re-elected to the Board of Directors and one of Ramius' nominees has been elected.

About Datascope Corp.

Datascope Corp. is the global leader of intra-aortic balloon counterpulsation and a diversified medical device company that develops, manufactures and markets proprietary products for clinical health care markets in interventional cardiology and radiology, cardiovascular and vascular surgery, anesthesiology, emergency medicine and critical care. The Company's products are sold throughout the world through direct sales representatives and independent distributors. Founded in 1964, Datascope is headquartered in Montvale, New Jersey. For news releases, webcasts and other Company information please visit Datascope's website,


Matthew Sherman / Michael Cuneo

Joele Frank, Wilkinson Brimmer Katcher

(212) 355-4449

Larry Dennedy / Joseph Doherty

MacKenzie Partners, Inc.

(212) 929-5500

SOURCE Datascope Corp.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Datascope Mails Letter to Shareholders
2. Datascope Files Investor Presentation
3. Datascope Recommends Shareholders Re-Elect its Two Incumbent Directors and Reject Ramius Opposition Slate
4. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
5. GPhAs 2007 Annual Policy Conference Features Top Generic Industry CEOs; FDA, Government Officials; Wall Street Analysts
6. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
7. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
8. inVentiv Health to Present at the 20th Annual Bear Stearns Healthcare Conference
9. Annual flu shot cuts need for doctors visits, hospitalization among children
10. Edwards Lifesciences to Present at the Bear Stearns 20th Annual Healthcare Conference
11. Johnson & Johnson to Participate in Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... treating sleep apnea using cutting-edge Oventus O2Vent technology. As many as ... disorder characterized by frequent cessation in breathing. Oral appliances can offer significant relief ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... NEW YORK , Sept. 27, 2017  DarioHealth Corp. ... big data solutions, today announced that its MyDario product is expected to ... TV listings for when The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, ... ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
(Date:9/19/2017)... , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company developing ... of targeted tissues, announced three leadership team developments today:   ... ... ... Veteran medical device executive Josh Stopek ...
Breaking Medicine Technology: